1 马建林,毛焕元.自制脂肪乳剂灌胃在家兔高脂血症模型制作中的应用[J].同济医科大学学报,1999;28(5):409-11 2 Kaminski KA, Bonda TA, Korecki J, Musial WJ. Oxidative stress and neutrophil activation-the two keystones of ischemia/ repeifusion injury[J]. Int J Cardiol, 2002; 86(1): 41-59 3 Sun B, Fan H, Honda T, Fujimaki R, Lafond-Walde A, Masui Y, et al. Activation of NF kappa B and expression of ICAM-1 in ischemic-reperfused canine myocardium[J]. J Mol Cell Car-diol, 2001;33(1):109-19 4 Ikeda U, Ikeda M, Kano S, Shimada K. Neutrophil adherence to rat cardiac myocyte by proinflammatory cytokines[J]. JCard-iovasc Phannacol, 1994; 23 (4): 647-852 5 Kacimi R, Karliner JS, Koudssi F, Long CS. Expression and regulation of adhesion molecules in cardiac cells by cytokines: response to acute hypoxia[J]. Circ Res, 1998;82(5):576-86 6 Youker KA, Hawkins HK, Kukielka GL, Perrard JL, Michael LH, Ballantyne CM, et al. Molecular evidence for induction of intracellular adhesion molecule-1 in the viable border zone assi-ciated with ischemia-reperfusion injury of the dog heart[J]. Circulation, 1994;89(6):2736-46 7 Metzler B, MairJ, LercherA, SchaberC, HintringerF, Pach-inger O, et al. Mouse model of myocardial remodelling after ischemia: role of intercellular adhesion molecule-1 [J]. Cardio-vasc Res, 2001; 49 (2): 399-407 8 Hartman JC, Anderson DC, Wiltse AL, Lane CL, Rosenbloom CL, Manning AM, et al. Protection of ischemic/reperfused ca-nine myocardium by CL18/6, a monoclonal antibody to adhesion molecule ICAM-1 [J]. Cardiovasc Res, 1995; 30(1): 47-54 9 Yokota N, O'Donnell M, Daniels F, Bume-Taney M, Keane W, Kasiske B, et al. Protective effect of HMG-CoA reductase inhibitor on experiment renal ischemia-repeifusion injury [J], Am J Nephrol, 2003;23(1): 13-7 10 Gueler F, Fong S, Prak JK, Fiebeler A, Menne J, Eiger M, et al. Postischemic acute renal failure is reduced by short-tenn statin treatment in a rat model[J]. JAM Soc Nephrol, 2002; 13 (9):2288-98 11 Ikeda Y,Young LH,Lefer AM. Rosuvastatin,a new HMG-CoA reductase inhibitou, protects ischemic reperfused myocar-dium in normocholesterolemic rats[J]. J Cardiovasc Pharmacol, 2003;41(4):649-56 12 Wayman NS, Hattori Y, Mcdonald MC, Mota-Filipe H, Cuzzo-crea S, Pisano B, et al. Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size[J]. FASEB J, 2002; 16(9): 1027-40 |